In search of new treatment strategies for medulloblastoma (2021 Brain Tumour Webinar Series)

Dr. Tamra Ogilvie, Associate Professor, Biochemistry & Medical Genetics at the University of Manitoba.

Dr. Ogilvie’s lab is working on medulloblastoma, a very aggressive pediatric brain tumor. There are at least 4 different kinds of medulloblastoma, all of which have very different clinical outcomes. One of these groups, called Sonic Hedgehog (SHH) medulloblastoma, is very high risk, as some patients survive while many others unfortunately die as a consequence of recurring disease and drug resistance. Thus, one of our goals is to identify new drugs to treat SHH medulloblastomas.

We recently discovered that SHH medulloblastoma cells are killed with a drug named selumetinib. This is exciting as selumetinib can actually get inside the tumor and is currently in clinical trials for the treatment of other children’s brain cancers. Now, we are testing the combination of selumetinib with other known cancer fighting drugs with the ultimate goal of increasing survival and enhancing the quality of life for those children who survive long term.


- - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Brain Tumour Webinar Series

This Brain Tumour Webinar Series features various webinars throughout the year with a variety of topics covered.

New for 2021 – Each webinar will feature both a speaker from the world of brain tumour research and/or medicine as well as a personal story of hope from a brain tumour survivor.
NOTE: There are nine webinars slated for 2021. There are no presentations in July, August or December.

This Brain Tumour Webinar Series features various webinars throughout the year, which will include topics around research, treatment, advance care planning, returning to work after a brain tumour diagnosis, personal stories from brain tumour survivors and caregivers, and more.

2021 Webinar Series details:
All presentations will run from 1:00​​​ – 2:15 pm EST
All presentations are free
Presentations may be subject to change. Check back often for updates
You must register for each webinar separately
All webinar presentations are recorded and uploaded to the Online Videos page within a week of the presentation date. If you register for a webinar but are unable to attend, you will receive a notice as to when the video is uploaded.

Download a poster for the 2021 Webinar Series:
http://2ya58i2cir0a4g93kospbp3u-wpeng...​

View/register for all available Brain Tumour Webinars:
https://www.braintumour.ca/webinars​​​

- - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Connect with Brain Tumour Foundation of Canada:
Facebook:   / braintumourf...​  
Facebook francophone:   / fondationcan​​​.  .
Twitter:   / braintumourfdn​​​  
Instagram:   / braintumour...​  
Pinterest:   / braintumour...​  

Call Toll Free 1-800-265-5106 or locally 519-642-7755 - call with any questions and connect today!

Brain Tumour Foundation of Canada
205 Horton St E, Suite 203,
London, ON N6B 1K7

http://www.BrainTumour.ca​​​

Charitable Registration #BN118816339RR0001​​​

Copyright and Terms of Use Statement - Videos
Copyright of all videos created by Brain Tumour Foundation of Canada on this website, including the underlying HTML, text, illustrations, designs, icons, audio clips, video clips, documents, products, software and all other content is either owned by the Brain Tumour Foundation of Canada, or Brain Tumour Foundation of Canada has obtained a license to use the materials.

The videos on the site are protected by the Copyright Act. None of the videos may be copied, reproduced, distributed, republished, downloaded, or transmitted in any form or by any means, without the prior written consent of Brain Tumour Foundation of Canada, or the original creator, where applicable.

All information within the videos has been posted to provide Canadians affected by a brain tumour with support, education, information and an understanding of research programs or to thank donors and supporters for their contributions. The information has been posted with the intent that it be readily available for personal and public non-commercial (educational) use. The allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, and research.